Entry Detail



General Information

Database ID:exR0090680
RNA Name:hsa-miR-18a-5p
RNA Type:miRNA
Chromosome:chr13
Starnd:+
Coordinate:
Start Site(bp):91350756End Site(bp):91350778
External Links:hsa-miR-18a-5p



Disease Information

Disease Name:Preterm Birth
Disease Category:Urogenital Diseases and Pregnancy Complications
MeSH ID:D047928
Type:Diseases Category/Female Urogenital Diseases and Pregnancy Complications
Alias:Premature Birth//Birth, Premature//Births, Premature//Premature Births//Preterm Birth//Birth, Preterm//Births, Preterm//Preterm Births



Expression Detail

GEO ID:GSE106224
Description:Exosomal RNA may reflect placenta deficiencies and provide better biomarker in preterm birth
Experimental Design:Disease vs Control
Case Disease Type:Preterm Birth
Case Disease SubType:NA
Case Sample:Preterm Birth
Control Sample:Control
Number of Case:20
Number of Control:50
Number of Samples:70





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
PATZ1
chr22
31325804
31346346
-
TUBA4A
chr2
219249710
219278170
-
SURF4
chr9
133361450
133376166
-
DDX5
chr17
64498254
64508199
-
SND1
chr7
127652194
128092609
+
HIF1AN
chr10
100529072
100559998
+
SIK2
chr11
111602449
111730855
+
FKBP1A
chr20
1368978
1393172
-
USP10
chr16
84699978
84779922
+
PARL
chr3
183829271
183884933
-
ASF1B
chr19
14119512
14136613
-
PRPF38B
chr1
108692310
108702928
+
ADAT2
chr6
143422832
143450695
-
ZNF12
chr7
6688433
6706947
-
DNAJC9
chr10
73183362
73247255
-
AC131160.1
chr3
183815568
183884889
-
ACSS2
chr20
34872146
34927962
+
MRPS18A
chr6
43671303
43687791
-
XRCC6
chr22
41621119
41664048
+
ROMO1
chr20
35699272
35700984
+
PEX5
chr12
7188685
7218574
+
NDUFV2
chr18
9102630
9134345
+
UBE2Z
chr17
48908407
48929056
+
NOP58
chr2
202265736
202303661
+
RNF4
chr4
2462220
2625320
+
CHD1
chr5
98853985
98928957
-
ATP2B1
chr12
89588049
89709300
-
SLC41A1
chr1
205789094
205813748
-
NCDN
chr1
35557473
35567274
+
HMGCS1
chr5
43287470
43313512
-
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000712
chr16
68208276
68225678
+
hsa_circ_0001186
chr21
35475133
35475818
+
hsa_circ_0001247
chr22
46125304
46136418
+
hsa_circ_0000921
chr19
30476129
30477324
+
hsa_circ_0000943
chr19
47421744
47440665
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC073896.4
chr12
56162359
56190284
-
AC093010.3
chr3
114314501
114329714
-
AC145207.5
chr17
81878425
81881106
-
AL162171.3
chr14
88589231
88592408
+
AP005263.1
chr18
9102736
9254346
+
CASC2
chr10
118046279
118210158
+
GAS5
chr1
173858559
173868882
-
NEAT1
chr11
65422774
65445540
+
SNHG1
chr11
62851984
62855953
-
SNHG15
chr7
44983023
44986961
-
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE106224
Sample Source:Blood
Source Fraction:Plasma
Platform:GPL18573
Method:NGS
Num of detected RNA Type:1
Num of detected RNAs of this Type:1522
Sample treatment protocol:Whole blood samples were centrifuged for 15 minutes at 2,000×g at 4°C to get plasma. EVs were isolated from 100 ul of plasma using size exclusion columns (iZON qEV, Cambridge MA) with de-gassed 1X PBS from a total of 22 selected samples, 11 from each group (Table 1). Eluate (~500 ul for each fraction) was collected in microfuge tubes individually. The protein contains and concentration for each fraction were assessed by protein gel electrophoresis and Bradford assay (BioRad, Hercules, CA).
RNA Extract protocol:RNA was isolated from all plasma samples, the 22 EV samples, and 22 corresponding EV-depleted fractions using miRNeasy Micro Kit (Qiagne, Germantown MD).
RNA library preparation protocol:Small RNA sequencing libraries were generated with a modified small RNAseq protocol (manuscript in preparation) that alleviates most of the adapter-miRNA ligation sequence bias problem.



Reference

PMID:29516617
Title:Extracellular vesicle RNAs reflect placenta dysfunction and are a biomarker source for preterm labour
Author:Fallen S, Baxter D, Wu X, Kim TK, Shynlova O, Lee MY, Scherler K, Lye S, Hood L, Wang K
Journal:J Cell Mol Med. 2018 May;22(5):2760-2773.
Description:We have used an improved small RNA library construction protocol and a newly developed size exclusion chromatography (SEC)-based EV purification method to gain a comprehensive view of circulating RNA in plasma and its distribution by analysing RNAs in whole plasma and EV-associated and EV-depleted plasma.